I |
CD29-A488 |
Mouse IgG1 |
TS2/16 |
Anti-human |
Biolegend, San Diego, CA |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:20 |
I |
CD44-APC |
Rat IgG2b |
IM7 |
Anti-mouse |
BD, Franklin Lakes, NJ |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:100 |
IV |
CD73 |
Mouse IgG1 |
10f1 |
Anti-human |
Abcam, Cambridge, UK |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:5 |
III |
CD90-APC |
Mouse IgG1 |
5E10 |
Anti-human |
BD, Franklin Lakes, NJ |
Hillmann et al. (2016) |
1:100 |
II |
CD105-PE |
Mouse IgG1 |
SN6 |
Anti-human |
Bio-Rad, Hercules, CA/Serotec, Kidlington, UK |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:10 |
II |
CD14-APC |
Mouse IgG1 |
134620 |
Anti-human |
R&D, Minneapolis, MN |
Braun et al. (2010) and Paebst et al. (2014) |
1:50 |
V |
CD14 biotinylated |
Mouse IgG1 |
105 |
Anti-equine |
Cornell University, Dr. Bettina Wagner |
Kabithe et al. (2010) |
1:1,500 |
III |
CD34-FITC |
Mouse IgG3 |
43A1 |
Anti-human |
AdipoGen Lifesciences, San Diego, CA |
Paebst et al. (2014) |
1:25 |
II |
CD45-A488 |
Mouse IgG2a |
F10-89-4 |
Anti-human |
Bio-Rad, Hercules, CA/Serotec, Kidlington, UK |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:5 |
VI |
CD79α-PE |
Mouse IgG1 |
HM57 |
Anti-human |
Bio-Rad, Hercules, CA/Serotec, Kidlington, UK |
Schauwer et al. (2012) and Paebst et al. (2014) |
1:50 |
I |
MHCII (equine), PE |
Mouse IgG1 |
CVS20 |
Anti-equine |
Bio-Rad, Hercules, CA/Serotec, Kidlington, UK |
Kydd et al. (1994) and Lunn et al. (1998), Schauwer et al. (2012), and Paebst et al. (2014) |
1:25 |
IV |
Goat anti-mouse Ig3, FITC |
Polyclonal IgG |
|
Anti-mouse |
Santa Cruz Biotechnology, Dallas, Texas |
|
1:100 |
V |
SAV-APC |
APC streptavidin |
|
|
Biolegend, San Diego, CA |
|
1:250 |